Clearline Capital’s Vincerx Pharma, Inc. Common Stock VINC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-4,946
| Closed | -$99.9K | – | 132 |
|
|
2023
Q3 | $99.9K | Hold |
4,946
| – | – | 0.01% | 122 |
|
|
2023
Q2 | $129K | Hold |
4,946
| – | – | 0.01% | 111 |
|
|
2023
Q1 | $103K | Hold |
4,946
| – | – | 0.02% | 107 |
|
|
2022
Q4 | $101K | Sell |
4,946
-17,663
| -78% | -$360K | 0.02% | 117 |
|
|
2022
Q3 | $624K | Hold |
22,609
| – | – | 0.07% | 111 |
|
|
2022
Q2 | $597K | Buy |
22,609
+1,976
| +10% | +$52.2K | 0.08% | 104 |
|
|
2022
Q1 | $1.65M | Buy |
20,633
+14,090
| +215% | +$1.13M | 0.19% | 82 |
|
|
2021
Q4 | $1.33M | Buy |
+6,543
| New | +$1.33M | 0.15% | 81 |
|